Porcine deltacoronavirus (PDCoV) is an emerging enteric virus characterized by high viral titers, strong immunogenicity, and broad host tropism, making it a promising candidate for developing vaccine vectors and foreign gene expression platforms. However, key aspects such as its transcription regulatory sequence (TRS) usage, reliable insertion sites, and the genetic stability of recombinant viruses remain incompletely understood. In this study, we established a reverse genetic system for the PDCoV strain DHeB1 and systematically evaluated the transcriptional activity of six TRS elements from the S, E, M, N, NS6, and NS7 genes. Each TRS was used to drive the expression of EGFP inserted between the N gene and 3' UTR of viral genome. The results showed that all TRSs could initiate EGFP expression, with the NS6-derived TRS exhibiting the strongest activity. However, all recombinant viruses carrying the EGFP cassette exhibited genetic instability, being passaged only up to seven times in LLC-PK1 cells, indicating that the region between the N gene and 3' UTR is unsuitable for stable foreign gene insertion. To improve genetic stability, while leveraging the strong promoter activity identified, we replaced the NS6 gene with the EGFP gene, as NS6 is an accessory protein whose deletion does not terminate viral replication. This recombinant virus was successfully rescued and stably propagated in LLC-PK1 cells for at least 15 passages, maintaining consistent EGFP expression. Collectively, this study provides an efficient reverse genetics platform for PDCoV, characterizes the transcriptional regulation of its TRS elements, and demonstrates the generation of a stable recombinant PDCoV expressing a foreign gene, thereby facilitating the development of PDCoV-based vector systems.
Seneca Valley virus (SVV), an emerging porcine picornavirus, has attracted significant attention recently as it presents a substantial threat to the global pork industry. Stimulator of interferon genes (STING) is an endoplasmic reticulum (ER)-associated adaptor protein that plays a crucial role in the type I interferon (IFN-I) signaling pathway, which triggers IFN-stimulated gene (ISG) production to elicit antiviral innate immunity. SVV has evolved numerous strategies to counteract the IFN-I signaling pathway and evade innate immunity. However, the mechanism underlying immune evasion in SVV infection remains unclear. In this study, we observed that SVV 2B and 3 C protease (3 Cpro) proteins promoted STING degradation to antagonize IFN-I activation through autophagy and caspase pathways, respectively. Mechanistically, 2B bound to STING, recruiting toll-interacting protein (Tollip) and neighbor of BRCA1 gene 1 (NBR1) to promote STING for autophagy degradation, and 2B prevented the STING-TBK1 interaction. Furthermore, SVV 3 Cpro antagonized host IFN-I signaling by cleaving interferon-stimulated gene 60 (ISG60) at Gln-406. The cleaved ISG60 products failed to inhibit SVV infection. Collectively, our study uncovered that SVV subverts the IFN-I response by targeting STING and ISG60, providing deeper insights into a novel mechanism utilized by SVV to antagonize the host's innate immune response.

